A multi-billion-dollar biomanufacturing campus expansion for one of the world’s largest pharmaceutical companies, with a Caribbean-based affiliate of a national design/engineering firm serving as Architect/Engineer of Record. Stelic has supported this project from early design through active construction, embedded inside the A/E’s design and program management team as the full-time project controls function, providing cost forecasting, scheduling, risk, and change management support across every phase and package.

Stelic maintains the master Primavera P6 schedule spanning four concurrent work packages (early civil and utility works, site access, the main production facility, and ancillary electrical/substation buildings), plus the offsite modular fabrication sequence run by a third-party manufacturing partner, keeping design progress, procurement sequencing, and construction logic aligned in a single logic-linked network.

Stelic built and maintains a set of interactive dashboards that give the design and program management team a live, data-driven view of the program instead of a static report. A procurement dashboard tracks every package’s status, review/bid/award milestones, and target on-site arrival dates against the schedule, surfacing lead-time exposure before it becomes a delay. A companion change order dashboard logs every owner- and design-driven change against authorized scope, with cost and schedule impact, approval status, and aging tracked in one place. Stelic issues weekly and monthly progress reporting across design, CQV, permitting, and procurement work streams, translating raw P6 and cost data into the narrative and visual format used in owner-facing program reviews.

Risk register management is active and continuous. Stelic tracks cross-package risks, including utility-authority approval sequencing for a new electrical substation, coordination gaps between site readiness and offsite module fabrication, and utility tie-in windows during commissioning, assigning ownership, mitigation status, and schedule/cost exposure to each item so the register drives decisions instead of just documenting them.

Change order management was implemented from the outset. Stelic evaluates the cost and schedule impact of owner- and design-driven changes against the authorized base scope, and supports formal notice and entitlement positions when scope disruption (most recently an active value-engineering review) introduces uncertainty on the critical path. Stelic prepares both the detailed, contract-referenced version of these notices and a condensed executive memo, so the same underlying analysis serves legal/commercial review and owner communication without duplicating effort.

For life sciences programs running multiple concurrent packages against a fixed regulatory and validation timeline, a controls function that doesn’t keep pace with design and procurement decisions is a liability. Stelic has operated inside this program’s design and controls process since early design, providing the cost, schedule, risk, and change management infrastructure that keeps phase-gate decisions informed and on time. The engagement continues